|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.800 USD | -0.55% |
|
-2.69% | -73.13% |
| 25-09-11 | GRI Bio Says Data Show No Lung Function Decline in Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis | MT |
| 25-04-01 | GRI Bio Prices up to $13 Million Equity Offering | MT |
| Market Cap | 5.39M 4.72M 4.35M 4.04M 7.67M 514M 7.77M 52.07M 20.27M 253M 20.25M 19.81M 875M | P/E 2021 |
-4.2x | P/E 2022 | -0.42x |
|---|---|---|---|---|---|
| Enterprise Value | 1.61M 1.41M 1.3M 1.21M 2.29M 154M 2.32M 15.56M 6.06M 75.47M 6.05M 5.92M 262M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
-
| Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -0.55% | ||
| Current month | -73.13% | ||
| Current year | -73.13% |
| 5 years | 1.77 |  | 310.8 |
| 10 years | 1.77 | | 310.8 |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -9.3M -8.15M -7.5M -6.97M -13.23M -887M -13.41M -89.83M -34.96M -436M -34.94M -34.17M -1.51B | -7.02M -6.15M -5.67M -5.26M -9.99M -670M -10.12M -67.82M -26.4M -329M -26.38M -25.8M -1.14B |
| Net Debt | -7.34M -6.43M -5.92M -5.5M -10.44M -700M -10.58M -70.89M -27.59M -344M -27.57M -26.96M -1.19B | -3.78M -3.31M -3.05M -2.83M -5.38M -361M -5.45M -36.51M -14.21M -177M -14.2M -13.89M -614M |
Employees
2
Sector
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | US$1.810 | 0.00% | 13,589 |
| 26-07-06 | US$1.810 | -3.21% | 49,685 |
| 26-07-02 | US$1.870 | +5.06% | 39,134 |
| 26-07-01 | US$1.780 | +0.56% | 46,826 |
| 26-06-30 | US$1.770 | -4.84% | 44,340 |
- Stock Market
- Stocks
- GRI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
